medac

• NCT06781879

  Collaborator, Phase 4, Recruiting, 272 people, 17 Jan 2025

• NCT06239311

  Phase 3, Recruiting, 277 people, 2 Feb 2024

• NCT04195633

  Collaborator, Phase 2, Recruiting, 60 people, 12 Dec 2019

• NCT03254589

  Collaborator, Phase 4, Completed, 124 people, 18 Aug 2017

• NCT02308553

  Collaborator, Phase 1/2, Completed, 33 people, 4 Dec 2014

• Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen

  Phase 1, Completed, 35 people, 26 Mar 2014

• Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient

  Phase 1, Completed, 105 people, 7 Jun 2013

• NCT01810926

  Collaborator, Phase 2, Status unknown, 130 people, 14 Mar 2013

• NCT00919503

  Collaborator, Phase 2, Completed, 98 people, 12 Jun 2009

• NCT00779714

  Collaborator, Phase 3, Status unknown, 360 people, 24 Oct 2008

Sources: clinicaltrials.gov

• Oral vitamin C supplementation in patients with clonal cytopenia of undetermined significance or lower-risk myeloid malignancies: Results from EVITA, a phase 2 randomized, placebo-controlled trial

  Grants or research support, 1 Oct 2026

• A clinical decision support tool for accurate hip fracture prediction: A nationwide cohort study

  Consulting or advice, Fees or honoraria, 27 Aug 2026

• Continuous map of early hematopoietic stem cell differentiation across human lifetime

  Fees or honoraria, Patents or royalties, 7 Mar 2025

Sources: pubmed.ncbi.nlm.nih.gov